HELIX COLLECTION
Explore the HELIX pharmaceutical collection with clear product information, formulation details and authenticity verification. Availability is subject to applicable law and professional requirements.
Browse by category
Products for this category will appear here once added.
Weight Loss
HELIX Retatrutide is presented as a 40mg injection pen kit. The listed formulation is a triple agonist acting on GLP-1, GIP and glucagon receptor pathways for controlled metabolic research.
| Total dose | 40mg |
|---|---|
| Pens per kit | 1 |
| Doses | 4 × 10mg |
| Listed increments | 2.5 / 5 / 7.5 / 10mg |
| Reference frequency | Once weekly |
| Mechanism | Triple agonist (GLP-1, GIP, glucagon) |
| Kit contents | 1 pen; 12 disposable needles; 1 information booklet. |
Weight Loss
HELIX Tirzepatide is presented as a 40mg injection pen kit. Its listed dual-agonist mechanism targets GLP-1 and GIP receptor pathways for metabolic and appetite-related research.
| Total dose | 40mg |
|---|---|
| Pens per kit | 1 |
| Doses | 4 × 10mg |
| Listed increments | 2.5 / 5 / 7.5 / 10mg |
| Reference frequency | Once weekly |
| Mechanism | Dual agonist (GLP-1, GIP) |
| Kit contents | 1 pen; 12 disposable needles; 1 information booklet. |
Weight Loss
HELIX Semaglutide is presented as an 8mg two-pen kit, with 4mg in each pen. The formulation is identified as a GLP-1 receptor agonist for controlled metabolic research.
| Total dose | 8mg (2 × 4mg) |
|---|---|
| Pens per kit | 2 |
| Listed increments | 0.25 / 0.5 / 0.75 / 1mg |
| Reference frequency | Once weekly |
| Mechanism | GLP-1 receptor agonist |
| Kit contents | 2 pens; 12 disposable needles; 1 information booklet. |
Weight Loss
HELIX CagriSema combines separately supplied Semaglutide and Cagrilintide pens. The formulation pairs a GLP-1 receptor agonist with a long-acting amylin analogue for dual-pathway appetite and metabolic research.
| Pen 1 | Semaglutide 4mg |
|---|---|
| Pen 2 | Cagrilintide 4mg |
| Pen 1 increments | 0.25 / 0.5 / 0.75 / 1mg |
| Pen 2 increments | 0.25 / 0.5 / 0.75 / 1mg |
| Reference frequency | Once weekly (same day) |
| Kit contents | 2 pens; 12 disposable needles; 1 information booklet. |
Weight Loss
HELIX Cagri Reta combines separately supplied Retatrutide and Cagrilintide pens. The kit pairs a triple-agonist formulation with an amylin analogue for dual-pathway metabolic and appetite-related research.
| Pen 1 | Retatrutide 40mg |
|---|---|
| Pen 2 | Cagrilintide 4mg |
| Pen 1 increments | 2.5 / 5 / 7.5 / 10mg |
| Pen 2 increments | 0.25 / 0.5 / 0.75 / 1mg |
| Reference frequency | Once weekly (same day) |
| Kit contents | 2 pens; 12 disposable needles; 1 information booklet. |
Recovery
HELIX Somatotropin HGH is presented as a 90 IU / 30 mg injection pen kit containing somatotropin (HGH). This entry identifies the formulation and supplied kit format for growth-hormone information.
| Total dose | 90 IU / 30 mg |
|---|---|
| Format | Injection Pen Kit |
| Compound | Somatotropin (HGH) |
| Kit contents | 1 pen; supplied needles; 1 information booklet. |
Recovery
HELIX HCG is presented as a 5000 IU / 3 mL informational product entry with a labelled click-volume reference. This page is for general education and verification context only.
| Total dose | 5000 IU / 3 mL |
|---|---|
| Reference conversion | 1 click = 16 IU |
| Format | Injection Pen Kit |
| Compound | Human chorionic gonadotropin (HCG) |
Recovery
HELIX BPC-157 & TB-500 is presented as a 40mg combined-peptide injection pen kit. The listed blend contains 12mg BPC-157 and 28mg TB-500 for laboratory recovery and tissue-response research.
| Total dose | 40mg |
|---|---|
| BPC-157 content | 12mg (30%) |
| TB-500 content | 28mg (70%) |
| Format | Injection Pen Kit |
| Kit contents | 1 pen; 12 disposable needles; 1 information booklet. |
Recovery
HELIX Biotin is presented as a 40mg injection pen kit containing biotin, also known as Vitamin B7. The catalogue entry is intended for nutritional, metabolic and cosmetic research reference.
| Total dose | 40mg |
|---|---|
| Compound | Biotin (Vitamin B7) |
| Format | Injection Pen Kit |
| Kit contents | 1 pen; 12 disposable needles; 1 information booklet. |
Recovery
HELIX NAD+ & NMN combines 600mg NAD+ and 400mg NMN in one 1000mg injection pen. The listed 60:40 composition is presented for cellular-energy, metabolism and longevity research.
| Total dose | 1000mg |
|---|---|
| NAD+ content | 600mg (60%) |
| NMN content | 400mg (40%) |
| Doses | 8 × 125mg |
| Reference frequency | Twice weekly |
| Kit contents | 1 pen; 12 disposable needles; 1 information booklet. |
Recovery
HELIX NAD+ & B12 combines NAD+ with Vitamin B12 in a single injection pen kit. The source-listed total dose is 1008mg, presented for cellular-energy, mitochondrial and neurological research.
| Total dose | 1008mg |
|---|---|
| Compounds | NAD+ and Vitamin B12 |
| Format | Injection Pen Kit |
| Kit contents | 1 pen; 12 disposable needles; 1 information booklet. |
Anabolic
HELIX TRT 600mg is presented as a testosterone cypionate injection pen kit for information and verification purposes. The package displays a reusable aluminium pen, 10 sterile needles and an instruction booklet. The click guide below is a labelled pen-volume reference only and is not personal dosing advice.
| Displayed compound | Testosterone cypionate |
|---|---|
| Displayed strength | 600mg |
| Format | Injection Pen Kit |
| Kit contents | 1 reusable aluminium pen; 10 sterile needles; 1 instruction booklet. |
| Click dosing guide | 5 clicks = 0.05 mL = 10 mg; 10 clicks = 0.10 mL = 20 mg; 15 clicks = 0.15 mL = 30 mg; 20 clicks = 0.20 mL = 40 mg; 25 clicks = 0.25 mL = 50 mg; 30 clicks = 0.30 mL = 60 mg; 35 clicks = 0.35 mL = 70 mg; 40 clicks = 0.40 mL = 80 mg; 45 clicks = 0.45 mL = 90 mg; 50 clicks = 0.50 mL = 100 mg |
| Important note | This guide describes labelled click-volume conversion only. Medical assessment and professional supervision are required before any use. |
Cosmetic
HELIX Melanotan II is presented as a 20mg nasal spray containing the MT2 peptide. The intranasal format is identified for pigmentation and cosmetic research reference.
| Total dose | 20mg |
|---|---|
| Format | Nasal Spray |
| Route | Intranasal |
| Compound | Melanotan II (MT2) |
| Kit contents | 1 nasal-spray bottle; 1 information booklet. |
Cosmetic
HELIX Glow Skin is presented as a 112mg triple-peptide injection pen containing 80mg GHK-Cu, 16mg BPC-157 and 16mg TB-500. The composition is listed for cosmetic, skin and tissue-response research.
| Total dose | 112mg |
|---|---|
| GHK-Cu content | 80mg |
| BPC-157 content | 16mg |
| TB-500 content | 16mg |
| Doses | 40 × 2.8mg |
| Reference frequency | Once daily (40 days, then 30-day break) |
| Route | Subcutaneous |
| Kit contents | 1 pen; 12 disposable needles; 1 information booklet. |
